Search

Author/Creator Mathers, Susan

12. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial. Issue 10 (October 2021)

Authors:
Cudkowicz, Merit; Genge, Angela; Maragakis, Nicholas; Petri, Susanne; van den Berg, Leonard; Aho, Valtteri V; Sarapohja, Toni; Kuoppamäki, Mikko; Garratt, Chris; Al-Chalabi, Ammar; Kiernan, Matthew; Mathers, Susan; Henderson, Robert; Needham, Merrilee; Schultz, David; Löscher, Wolfgang; Mitrovic,...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 10(2021)
Page Start:
821
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial. Issue 7 (2nd October 2019)

Authors:
Gold, Julian; Rowe, Dominic B.; Kiernan, Matthew C.; Vucic, Steve; Mathers, Susan; van Eijk, Ruben P. A.; Nath, Avindra; Garcia Montojo, Marta; Norato, Gina; Santamaria, Ulisses A.; Rogers, Mary-Louise; Malaspina, Andrea; Lombardi, Vittoria; Mehta, Puja R.; Westeneng, Henk-Jan; van den Berg, Leon...
Journal:
Amyotrophic lateral sclerosis and frontotemporal degeneration
Issue:
Volume 20:Issue 7/8(2019)
Page Start:
595
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. The impact of communication on healthcare involvement for people living with motor neurone disease and their carers: A longitudinal qualitative study. Issue 6 (21st July 2022)

Authors:
Paynter, Camille; Mathers, Susan; Gregory, Heidi; Vogel, Adam P.; Cruice, Madeline
Journal:
International journal of language & communication disorders
Issue:
Volume 57:Issue 6(2022)
Page Start:
1318
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗